ED 1-1973 Goes International, editorial

EDI-1973 Goes International

I. Acetohexam ide- Phenylbutazone (1)

"*

Summary: C lin ical Application

Phenylbutazone ~ %.).1 011 *%i>~nJ Acetohexamide.9i

~1

-o-J cJ-

0] t4l oJ1-c-'

iLj!~ 7 ~ ~ 7~i>}~..£.

Acetohexamide~ .itt ~ ~04 o~ ctlcf. o]~ 0--l=% 'M- Jij !It % -* % t5H.x. ~].2J- 7J ~ iL J!t 7}. Y. E-} t-J- 4. ::l

7.i.i't

cJ-ktlj ~l :;i:}.li.7} 7.} 0J~ 01

~~

~~}

Oxyphenbutazone.x. Phenyl buta zoneJ!t %A~

4. o-J o:j

~..
AJ 01] Indomethac in ~ A~% i>~?l] ~

-c- c-l]

Phenylbutazone~

%

-c-

01} ~1-c- ~l ~ ~% ~

.g. ~1-o-J cJ- Ail9-J- AJ- ~ ~r%~~5.. AJ- ~~%i>}C-l r..} ""~ 7--l-.!8. 4. t4ct~1 Indomethac in% ~1 -o-J cJ- A11.2t tlj % ~ ttll ~ .y~~­ t5H o~

0]

t:ll 0--l=%

-r 4.2

]i.2~

Phenformin~

4%01] oJ ~J:

tit ~ ?tL~-~..£. ~ ~ ~Al-01}71] cH ~ oj] Pheny lbu ta zone %

Acetohexam ide

A}%i>~-c- ~ol ~4. etohexamide~

tI}T-c-c-n -c-

J21Y-

~~~01

04 21 7 }:A]

Phenfomin.:4 Ac-

q{=7J ~2i.2 ~1-o-JcJ-~1~~

012~ ~ -r~] 7}

-e.§t:1-.

For an English translation of the above text, please refer to page one of your copy of the American Pharmaceutical Association's Evaluations of Drug Interactions-1973. Yes, that's right! The drug interaction monograph section of EDI-1973 has been translated and published in a recently released text entitled Clinical Pharmacy, edited by Yun Sung Chough, chairman, department of pharmacodynamics, Seoul National University College of Pharmacy, Seoul, Korea. In April 1973, APhA published and distributed to all Association members the first edition of EDI which revolutionized the drug interaction information scene. The text gained international prominence almost at once when the Australasian Pharmaceutical Publishing Company, Ltd., and The Pharmaceutical Society of Great Britain -recognizing the importance of the pUblication - undertook to distribute it in their respective geographical areas. Since then, EDI-1973 has become by official decree a required text in all pharmacies in at least one Australian state. Further, EDI-1973 is a mainstay of pharmacy eduction in the U.S.A. and Canada. APhA has not only expressed its concern about health care problems attributable to improper drug utilization, th€: Association has been a leader in attempting to do something meaningful about it. The Association has for many years urged pharmacists to maintain patient medication records. [See the July 1973 issue of this Journal on patient record systems, as well as an historical insight into the early use of this most useful tool in preventing adverse drug reactions and interactions by Aaron Silnutzer and JackW. Dorsey on pages 552-554 of this issue.] To increase the effectiveness of patient medication record systems, and to increase the knowledge of both pharmacists and physicians regarding adverse drug interactions, APhA last year published Evaluations of Drug Interactions-1973. This volume has been recognized as a definitive work on this subject not only in this country but in several others.

This is how APhA Executive Director William S. Apple described APhA's activities in this area to the Senate Subcommittee on Health on May 21. Now we see that not only geographical boundaries, but language barriers as well have been transcended by the translation of EDI-1973 into the Korean language in'the interest of improving the quality of pharmaceutical services provided to patients in that Asian country. Dr. Chough and his co-editors, using information from EDI-1973 as well as selected "Current Therapeutic Concepts" articles originally published in this Journal, have produced a Korean-language text which they feel will greatly aid in "the required new concept of the pharmacists' responsibilities in the field of medical treatment of patients in Korea." The action of the APhA Board of Trustees which resulted in the implementation of the Association's Drug Interactions Project has borne a "bumper crop" of rewards. The worldwide acceptance of EDI-1973 is certainly proof of this fact. Moreover, the decision of the Board to authorize the continuation of the Project (see opposite page) underscores the Association's commitment to maintain its leadership position in the drug information area, to provide membership services, and, most important, to contribute to public health. The enthusiasm with which EDI-1973 has been received and its information subsequently applied to pharmacy practice and pharmacy education is most gratifying. The fact that this is now also occurring worldwide is a further indication that U.S. pharmacists are at the forefront of providing comprehensive pharmaceutical services to their patients.

--George B. Griffenhagen Vol. NS14, No.7, July 1974

339